Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology
Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines
Want to get your story featured as above? click here!
Want to get your story featured as above? click here!